Valneva Announces Closing of $107.6 million Global Offering
11 Maggio 2021 - 7:00AM
Saint-Herblain
(France), May 11, 2021 – Valneva
SE, a specialty vaccine company focused on the development and
commercialization of prophylactic vaccines for infectious diseases
with significant unmet medical need, today announced the closing
which occurred on May 10, 2021 of its previously announced global
offering to specified categories of investors of an aggregate of
8,145,176 new ordinary shares, after full exercise of the
overallotment option granted to the underwriters (the
“Option”), consisting of a public offering of
2,850,088 American Depositary Shares (“ADSs”),
each representing two ordinary shares, in the United States at an
offering price of $26.41 per ADS (the “U.S.
Offering”), and a concurrent private placement of
2,445,000 ordinary shares in Europe (including in
France) and other countries outside of the United States at
the corresponding offering price of €11.00 per ordinary share (the
“European Private Placement”, and, together with
the U.S. Offering, the “Global Offering”).
Aggregate gross proceeds of the Global Offering, after full
exercise of the Option, before deducting underwriting commissions
and estimated expenses payable by the Company, were approximately
$107.6 million (€89.6 million).
Valneva's ordinary shares are listed on Euronext
Paris under the symbol “VLA” and its ADSs are listed on the Nasdaq
Global Select Market under the symbol “VALN”. The ADSs began
trading on the Nasdaq Global Select Market on May 6, 2021.
Goldman Sachs, Jefferies, Guggenheim Securities
and Bryan, Garnier & Co. acted as joint bookrunners for the
Global Offering. Namsen Capital acted as Valneva’s capital markets
advisor.
The Company has filed a registration statement,
including a prospectus, relating to these securities with the U.S.
Securities and Exchange Commission (“SEC”), which
was declared effective by the SEC on May 5, 2021. The offering was
made by means of a prospectus and copies of the prospectus relating
to and describing the terms of the Global Offering may be obtained
from Goldman Sachs & Co. LLC, Attention: Prospectus Department,
200 West Street, New York, New York 10282, telephone: 866-471-2526,
facsimile: 212-902-9316, e-mail: prospectus-ny@ny.email.gs.com or
Jefferies LLC, Attention: Equity Syndicate Prospectus Department,
520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone
at +1 877 821 7388 or by email
at Prospectus_Department@Jefferies.com.
About Valneva SE
Valneva is a specialty vaccine company focused
on the development and commercialization of prophylactic vaccines
for infectious diseases with significant unmet medical need. The
Company has leveraged its expertise and capabilities both to
successfully commercialize two vaccines and to rapidly advance a
broad range of vaccine candidates into and through the clinic,
including candidates against Lyme disease, the chikungunya virus
and COVID-19.
For additional information, please
contact:
Valneva Investor and Media ContactsLaetitia
Bachelot-FontaineDirector Investor Relations & Corporate
CommunicationsM +33 (0)6 4516 7099investors@valneva.com
DISCLAIMER
This press release does not constitute an offer
to sell or the solicitation of an offer to buy securities in any
jurisdiction, and shall not constitute an offer, solicitation or
sale in any jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the
securities laws of that jurisdiction. The registration statement
can be accessed by the public on the website of the SEC.
This announcement is an advertisement and not a
prospectus within the meaning of Regulation (EU) 2017/1129 of the
European Parliament and of the Council of 14 June 2017, as amended
(the “Prospectus Regulation”).
In France, the European Private Placement
described above will take place solely as a placement to the
benefit of categories of persons, in accordance with Article L.
225-138 of the “Code de commerce” and applicable regulations. The
European Private Placement is reserved, in Europe (including in
France), to "qualified investors", as that term is defined in
Article 2(e) of the Prospectus Regulation.
In relation to each member state of the European
Economic Area other than France (each, a “Relevant Member
State”), an offer of the securities referred to herein is
not being made and will not be made to the public in that Relevant
Member State, other than: (i) to any legal entity which is a
qualified investor as defined in the Prospectus Regulation; (ii) to
fewer than 150 natural or legal persons per relevant member state;
or (iii) in any other circumstances falling within Article 1(4) of
the Prospectus Regulation; provided that no such offer of the
securities referred to herein shall require the Company to publish
a prospectus pursuant to Article 3 of the Prospectus Regulation.
For the purposes of the above, the expression an “offer to the
public” in any Relevant Member State shall have the meaning
ascribed to it in article 2(d) of the Prospectus Regulation.
This communication is being distributed only to,
and is directed only at (a) persons outside the United Kingdom, (b)
persons who have professional experience in matters relating to
investments falling within Article 19(5) of the Financial Services
and Markets Act 2000 (Financial Promotion) Order 2005 (the
"Order"), and (c) high net worth entities, and
other persons to whom it may otherwise lawfully be communicated,
falling within Article 49(2) of the Order (all such persons
together being referred to as "relevant persons").
Any investment or investment activity to which this communication
relates is available only to relevant persons and will be engaged
in only with relevant persons. Any person who is not a relevant
person should not act or rely on this communication or any of its
contents.
This press release has been prepared in both
French and English. In the event of any differences between the two
texts, the French language version shall supersede.
- 2021_05_11_VLA_Closing_PR_EN_Final
Grafico Azioni Valneva (EU:VLA)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Valneva (EU:VLA)
Storico
Da Apr 2023 a Apr 2024